1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. GENMAB - ADR
Genmab - ADR XNAS: GMAB

Genmab (ADR) Live Stock Price Today, Share Analysis and Chart

Strong Performer, Getting Expensive
about

Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab's proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and HexElect. Johnson & Johnson partnered with Genmab...

Read More
33.55 -0.40 (-1.18%)
New 52W High in past week
1.4M
XNAS Volume

XNAS 13 Jan, 2026 2:12 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The board meeting for Genmab (ADR) is scheduled for today, for the purpose of 44th Annual J.P. Morgan Healthcare Conference See details
Durability score
High Financial Strength
61.1 / 100
Valuation Score
Mid Valuation
49.2 / 100
Momentum Score
Technically Bullish
71.3 / 100
Strong Performer, Getting Expensive These stocks are strong in quality and technicals but have medium valuation. At somewhat expensive valuations, investors should be cautious before buying View Similar Embed DVM
Analyst Price Target
38
1Yr Price target upside is 13%
7 analysts

21

S

8

W

5

O

1

T

SWOT Analysis

Genmab (ADR) Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..